2025-01-30 12-16-01
Content
- Back Pain in the Lumbar Spine can be reduced within 3 months after injection of 10±5 million Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into a non-torn Intervertebral Disc (IVD) at L5-S1, L4-L5, or both levels
References
| Insights3 | |
|---|---|
| 2025-01-30 12-15-27 | Back Pain in the Lumbar Spine is reduced by an average of 71% at 12 months after injection of 10±5 million Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into a non-torn Intervertebral Disc (IVD) at L5-S1, L4-L5, or both levels |
| 2025-01-30 12-13-47 | Back Pain in the Lumbar Spine is reduced by an average of 69% at 6 months after injection of 10±5 million Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into a non-torn Intervertebral Disc (IVD) at L5-S1, L4-L5, or both levels |
| 2025-01-30 12-11-56 | Back Pain in the Lumbar Spine is reduced by an average of 62% at 3 months after injection of 10±5 million Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs) into a non-torn Intervertebral Disc (IVD) at L5-S1, L4-L5, or both levels |
| Original Sources1 | Citations |
|---|---|
| orozcoIntervertebralDiscRepair2011 | Orozco, Lluis, Robert Soler, Carles Morera, Mercedes Alberca, Ana Sánchez, and Javier García-Sancho. “Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study.” Transplantation 92, no. 7 (October 15, 2011): 822–28. https://doi.org/10.1097/TP.0b013e3182298a15. |